400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
2022-01-20
Ceptur Therapeutics Inc
靶向寡核苷酸疗法开发商
医药研发/制造
化学&生物药
PXV Fund;
PXV Fund;
Boxer Capital;
Boxer Capital;
百时美施贵宝;
VenBio Partners;
启明创投;
Affinity Asset Advisors;
LifeSci Venture Partners;
Janus Henderson Investors
GlobeNewswire2026-03-10
PRNewswire2026-03-10
PRNewswire2026-03-10
GlobeNewswire2026-03-10
PRNewswire2026-03-10
GlobeNewswire2026-03-10
PRNewswire2026-03-10
GlobeNewswire2026-03-10
PRNewswire2026-03-10
PRNewswire2026-03-10